Audible. Only £0.99 a month for the first 3 months. Auto-renews at £7.99/mo, after 3 months. Ends January 21, 2025. Start my membership

POWERHOUSE April 2024: The Mito Fund & Pierrepont Therapeutics
Apr 30 2024
Length: 48 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to basket failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Unfollow podcast failed

POWERHOUSE April 2024: The Mito Fund & Pierrepont Therapeutics

Listen for free

View show details

Summary
In this latest episode, join UMDF's Brian Harman and Dr. Philip Yeske in a talk with guests, Todd Lacey from the UMDF Board of Trustees and Dan DiPietro, Co-Founder of Pierrepont Therapeutics. On the advent of The Mito Fund's inaugural investment in Pierrepont's enzyme replacement therapy for patients with MNGIE, they share insight on the potentially game-changing research investment and new strategic partnership.

Show More Show Less

Show More Show Less

What listeners say about POWERHOUSE April 2024: The Mito Fund & Pierrepont Therapeutics

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon